AIM ImmunoTech Inc.

United States of America


Create a watch for AIM ImmunoTech Inc.
Total IP 50
Total IP Rank # 28,360
IP Activity Score 2.3/5.0    26
IP Activity Rank # 30,056
Stock Symbol
ISIN US00901B1052
Market Cap. 75.80M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

19 6
10 1
11 0
3
 
Last Patent 2024 - Compositions and methods for enh...
First Patent 2006 - Dsrnas as influenza virus vaccin...
Last Trademark 2025 - ALFERON N INJECTION
First Trademark 1986 - ALFERON

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Interferons; parenterally administered interferons for use in treating viral diseases and immunol...
2022 Invention Compositions and methods for enhancing and expanding infection induced immunity. Methods and com...
Invention Compositions and methods for enhancing and expanding infection induced immunity. Methods and comp...
Invention Compositions and methods for treating post-covid conditions of fatigue. Disclosed is a method fo...
Invention Compositions and methods for treating post-covid conditions of fatigue. Disclosed is a method for...
G/S Intravenous solution for use in the treatment of viral infections, ME/CFS, and Neoplastic disease...
Invention Compositions and methods for treating long covid. This disclosure relates to compositions and me...
Invention Methods and compositions for treating neuroinflammation. Methods and compositions for treating, ...
Invention Methods and compositions for treating neuroinflammation. Methods and compositions for treating, r...
2021 Invention Compositions and methods for treating cancer. Disclosed is a method for treating a cancer, such ...
Invention Compositions and methods for treating cancer. Disclosed is a method for treating a cancer, such a...
Invention Compositions and methods for treating long covid. This disclosure relates to compositions and met...
Invention Compositions for cancer therapy and methods. One aspect of this disclosure is directed to a meth...
Invention Therapeutic double stranded rna and methods for producing the same. Disclosed is a method for the...
Invention Methods, compositions, and vaccines for treating a virus infection. This disclosure relates to a...
Invention Methods, compositions, and vaccines for treating a virus infection. This disclosure relates to a ...
2020 Invention Methods and compositions for treating endometriosis. Disclosed is a method for treating endometri...
G/S Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and M...
Invention Compositions and methods useful for ebola virus infection. Disclosed are methods and composition...
Invention Compositions and methods useful for ebola virus infection. Disclosed are methods and compositions...
2019 Invention Compositions and methods for cancer therapy. One aspect of this disclosure is directed to a meth...
Invention Compositions and methods for cancer therapy. One aspect of this disclosure is directed to a metho...
Invention Methods for improving exercise tolerance in myalgic encephalomyelitis patients. The present inven...
Invention Compositions for cancer therapy and methods. One aspect of this disclosure is directed to a metho...
2014 Invention Method of reducing antigenic drift or reassortment of viruses in a host animal using α interferon...
Invention Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biol...
2007 Invention Broad spectrum immune and antiviral gene modulation by oral interferon. An antiviral/immunomodula...
Invention Treating severe acute respiratory syndrome. Severe acute respiratory syndrome is treated with a n...
2006 Invention Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants. Vaccine protection against acut...
Invention Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants.
Vaccine protection a...
1988 G/S Intravenous solution for use in the treatment of viral infections.
1986 G/S INTRAVENOUS SOLUTION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
G/S INTERFERONS